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Generation of microalga 
Chlamydomonas reinhardtii 
expressing shrimp antiviral dsRNA 
without supplementation of 
antibiotics
patai Charoonnart1,2, Nichakorn Worakajit3, Julie A. Z. Zedler4,5, Metha Meetam3, 
Colin Robinson4 & Vanvimon Saksmerprome1,2
RNA interference (RNAi) is an effective way of combating shrimp viruses by using sequence-specific 
double-stranded (dsRNA) designed to knock down key viral genes. The aim of this study was to use 
microalgae expressing antiviral dsRNA as a sustainable feed supplement for shrimp offering viral 
protection. In this proof of concept, we engineered the chloroplast genome of the green microalga 
Chlamydomonas reinhardtii for the expression of a dsRNA cassette targeting a shrimp yellow head 
viral gene. We used a previously described chloroplast transformation approach that allows for 
the generation of stable, marker-free C. reinhardtii transformants without the supplementation of 
antibiotics. The generated dsRNA-expressing microalgal strain was then used in a shrimp feeding 
trial to evaluate the efficiency of the algal RNAi-based vaccine against the virus. Shrimps treated 
with dsRNA-expressed algal cells prior to YHV infection had 50% survival at 8 day-post infection 
(dpi), whereas 84.1% mortality was observed in control groups exposed to the YHV virus. RT-PCR 
using viral specific primers revealed a lower infection rate in dsRNA-expressing algae treated shrimp 
(55.6 ± 11.1%) compared to control groups (88.9 ± 11.1% and 100.0 ± 0.0%, respectively). Our 
results are promising for using microalgae as a novel, sustainable alternative as a nutritious, anti-viral 
protective feedstock in shrimp aquaculture.
The shrimp aquaculture industry remains threatened by significant losses due to several viral pathogens such as 
the yellow head virus (YHV) and the white spot syndrome virus (WSSV). RNA interference (RNAi) technology 
is a novel, highly effective technology for combating viral pathogens by using sequence-specific double-stranded 
(dsRNA) designed to knockdown the key viral genes. This method aims to harness the natural abilities of animals 
to combat pathogen infections. The application of this technology in small-scale tests suggests high efficiency of 
RNAi in controlling shrimp viruses that cause high mortality rates and slow growth syndrome1,2. For large-scale 
production, the utilization of a RNase III-deficient Escherichia coli strain expressing gene-specific dsRNA is 
efficient and inexpensive1. However, regular use of E. coli cells in shrimp feed has yet to be investigated for its 
long-term effect on the animals and the environment. Thus, finding alternative dsRNA production and delivery 
systems that can be safely used in shrimp farms is a key challenge for future application of this technology.
The eukaryotic green microalga Chlamydomonas reinhardtii has been investigated as a cell factory for the 
production of a wide range of biomolecules. The GRAS (Generally Regarded As Safe) status of this alga and the 
lack of any endotoxin production and infectious agents makes it particularly attractive3. Using this microalga 
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as shrimp feedstock could, therefore, be an attractive alternative that would not raise concerns of health risk or 
environmental contamination4. Moreover, well-established genetic engineering tools for nuclear and chloroplast 
genome modification and gene expression are available for this microalga5,6.
The potential of dsRNA produced from the nuclear genome of C. reinhardtii to protect shrimps from YHV 
infection was previously shown7. Meanwhile, the chloroplast has become an attractive target for dsRNA produc-
tion since it lacks any RNAi machinery for dsRNA processing allowing high-level accumulation of dsRNA within 
the organelle8. In addition, chloroplast transformation in C. reinhardtii occurrs via homologous recombination 
leading to integration of the gene of interest in a specific site whereas integration into the nuclear genome occurs 
randomly causing instability and issues with gene silencing9. More importantly, chloroplast transformation can 
be achieved by utilizing non-photosynthetic mutant strains, allowing for the generation of marker-free trans-
formants that do not require antibiotics for selection10.
Economou et al. (2014) have established a simple and low-cost method for chloroplast transformation in 
C. reinhardtii by developing a non-photosynthetic (PSII-), cell wall-deficient psbH-knockout recipient strain 
(TN72)11. Transformation of this strain with a plasmid containing double homologous recombination loci and 
a functional psbH gene allows for insertion of the GOI using phototrophic growth as a selection pressure. The 
system has proven its practicality and reliable approach for producing several biochemical compounds such as a 
diterpene synthase and human growth hormone12,13. Thus, our aim was to exploit this system for shrimp antiviral 
dsRNA production in the C. reinhardtii chloroplast.
In this study we generated a stable, homoplasmic C. reinhardtii chloroplast transformant expressing a dsRNA 
specific to the YHV shrimp virus and demonstrated the efficiency of the algal transformant as feed supplement 
for shrimp disease control.
Materials and Methods
Strains and culture maintenance. The Chlamydomonas reinhardtii strain CC-5168 (cw15, ∆psbH, SpecR) 
a cell wall-deficient strain lacking a functional psbH gene, and thus PSII−, was used for chloroplast transformation 
(Chlamydomonas Resource Center, University of Minnesota, USA). The strain is also commonly referred to as 
“TN72”, which is how we will refer to it in this study. All algal strains were generally maintained by re-streaking 
on Tris Acetate Phosphate (TAP) pH 7.0 agar every 3 weeks and cultivated at 25 °C under low-intensity light. For 
all experiments in liquid culture, pre-cultures were prepared by inoculating liquid TAP medium from an agar 
plate and incubated for 4–5 days with continuously shaking at 100 rpm under low-intensity light.
Construction of dsRNA-expression cassette and C. reinhardtii PYP strain generation by chlo-
roplast transformation. A 374-bp fragment of the RNA-dependent RNA polymerase (RdRp) of the 
Yellow Head Virus (YHV) was used as target gene1. A double-stranded RNA expression cassette was designed 
using head-to-head promoters, so-called convergent promoters, for a sense-antisense expression approach 
(Fig. 1a). The construct was designed to obtain a fragment-of-interest (FOI) linked with an inverted psaA pro-
moter at the downstream of the fragment. The designed fragment was custom-synthesized by GenScript (USA) 
(pUC-FOI-psaAin) (see Supplementary Material for gene sequence). The FOI-psaA sequence was then inserted 
into the plasmid pSRSapI12 suitable for C. reinhardtii TN72 chloroplast transformation. This plasmid was pur-
chased from the Chlamydomonas Resource Center (University of Minnesota, USA). FOI-psaAin was cut and 
ligated with pSRSapI using the restriction sites NcoI and SphI (Fig. 1a). The correct plasmid assembly was 
Figure 1. (a) Construction procedure of convergent promoter cassette expressing dsRNA. The cloning of 
fragment-of-interest (FOI) linked with an inverted psaA promoter (pUC-YHV_RdRp-psaAin) (I) into pSRSap 
I generating recombinant plasmid for chloroplast transformation (pSRSapI-FOI-psaAin) (II). (b) PCR analysis 
confirming insertion and direction of FOI-psaA in pSRSap I using primers Y1 and rbcl illustrated on the left 
whereas lane M is 2-log DNA marker, lane T represents pSRSapI-FOI-psaAin (pSR-PYP), and lane E represents 
pSRSapI.
3Scientific RepoRts |          (2019) 9:3164  | https://doi.org/10.1038/s41598-019-39539-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
confirmed by PCR and named pSRSapI-FOI-psaAin (pSR-PYP). The NotI restriction site was introduced for 
convenient replacement of the FOI with other viral targets.
Chloroplast transformation using glass beads was performed following a protocol described previously11. In 
brief, 10 mL of a pre-culture were inoculated into fresh 400 mL TAP medium and grown to an OD750 nm between 
1.0 and 1.2. The cells were then harvested and concentrated 100-fold. For each transformation, 300 µL of con-
centrated cells were transferred in a 5-ml tube containing approximately 300 mg acid washed and autoclaved 
glass beads (diameter: 400–625 µm). Five to ten micrograms of pSR-PYP plasmid were then added to each tube 
followed by vortexing at maximum speed for 15 s. Cells were immediately mixed with melted High salt medium 
(HSM) soft agar and directly poured on HSM agar plates. The plates were incubated in the dark overnight prior 
to illumination with 50 µmol photon m−2 s−1 for three to four weeks.
Genotyping and homoplasmy analysis of C. reinhardtii transformants. The individual colonies 
obtained were picked and re-streaked on fresh HSM plates. After three passages, colonies were genotyped. Total 
genomic DNA was obtained by colony resuspension in Tris-EDTA (TE) buffer pH 8.0 and extraction of DNA 
using a CTAB based method14. As a control for successful chloroplast DNA extraction, the housekeeping gene 
rbcL (NCBI Accession No. BK00054.2) was amplified by Polymerase Chain Reaction (PCR) using the primers 
RBCL_F and RBCL_R (Table 1) (RBC Bioscience, Taiwan). Successful integration of the dsRNA-expression cas-
sette was detected with FOI specific primers (Y1 and Y2). To confirm homoplasmy of the transformants, the 
TN72 chloroplast genome sequence using the primers TN72_F (W1) annealing upstream of the left flanking 
region and TN72_R (W2) annealing between the left and right flank (see Fig. 2a) was amplified. Homoplasmic 
strain was chosen and passaged on TAP agar for further use and named as PYP.
Growth analysis. The growth of the generated C. reinhardtii strain expressing dsRNA-YHV (PYP) was ana-
lyzed in direct comparison to a control strain (TN72 transformed with the pSRSapI plasmid) previously gen-
erated15. Pre-cultures of both strains were prepared as described in Section 2.1 and 10 mL of each strain were 
re-inoculated into 400 mL TAP medium with continuous shaking at 100 rpm and 50 µmol photons m−2 s−1 
illumination at 25 °C. Growth analysis was performed in triplicates by daily measurements of optical density at 
750 nm until reaching stationary phase. Averages from biological triplicates were calculated, error bars show the 
standard deviation (n = 3).
Specific dsRNA analysis and quantitation using RT-PCR and RT-qPCR. Total RNA of the 
PYP transformant was extracted at late-log phase from a 400-mL culture using TRIZOL (Ambion, USA). 
Double-stranded RNA was obtained by treating total RNA with DNase for 6 h at 37 °C to remove any genomic 
DNA, and RNase A for 1 h at 37 °C to remove any single-stranded RNA. The resulting dsRNA was confirmed by 
RT-PCR using the primers YHV_F and YHV_Rin (Table 1) (PCR Biosystem, UK). The presence of dsRNA was 
confirmed by digesting purified dsRNA with RNase III for 1 h followed by RT-PCR to observe dsRNA clearance.
To quantify dsRNA-YHV, 500 ng of treated total RNA was subjected to RT-qPCR (KAPA Biosystem, USA) 
using YHV_F and YHV_Rin primers. The sample was heated to 95 °C for 5 min, followed by immediate place-
ment on ice for 1 min to unwind dsRNA prior to qRT-PCR16. A standard curve was prepared using ten-fold 
dilutions of known amount of dsRNA-YHV expressed from E. coli HT1151. Double-stranded RNA was calculated 
according to a formula obtained from the standard curve (R2 = 0.954).
Shrimp feeding trial. Penaeus vannamei shrimp at post larval (PL) 30 were used for a feeding trial and a 
viral challenge test. The shrimp were acclimatized in 10 ppt of artificial seawater with aeration three days prior to 
the experiment. Shrimp were randomly divided into 4 groups (n = 25) with 3 replicates for each group cultivated 
in glass tank containing 2 L artificial seawater. Shrimp in groups 1 and 2 served as a negative (no algal treatment, 
no challenge) and a positive control (infection with YHV only), respectively. For Groups 3 and 4, 5 × 105 cells per 
mL seawater of algal cells (C. reinhardtii strain SR and PYP, respectively) were added to the shrimp culture vessels 
every day. At day 3 of the experiment, shrimp in groups 2, 3 and 4 were fed with YHV-infected homogenized 
Name in diagram Primer names Sequences Function References
Y1 YHV_F 5′ GCATGTCCTGTTCTC 3′
dsRNA-YHV (RdRp) specific primers (FOI) 1
Y2 YHV_Rin 5′ GAATTCTAGCCATGC 3′
psaA psaA_pro_F 5′ GCGTTGCTAATGGTGTAAAT 3′
dsRNA-expressing cassette checking
Own designed
rbcl RbCL_ter_R 5′ CACATGCAGCAGCAAGTTCT 3′
RBCL_F 5′-GTCACCACCAGACATACGAAG-3′
Internal control for chloroplast DNA extraction
RBCL_R 5′ GGTCACTACTTAAACGCTAC 3′
W1 TN72_F 5′ GTCATTGCGAAAATACTGGTGC 3′ Homoplasmic status checking (wildtype-
derived primers)
11
W2 TN72_R 5′ CGGATGTAACTCAATCGGTAG 3′
GY2 5′ CATCTGTCCAGAAGGCGTCTATGA 3′
YHV detection (out of dsRNA specific region)
7
GY3 5′ ACGCTCTGTGACAAGCATGAAGTT 3′
Actin_F 5′ CCTCGCTGGAGAAGTCCTAC 3′
Internal control for Shrimp RNA extraction
Actin_R 5′ TGGTCCAGACTCGTCGTACTC 3′
Table 1. List of primers used in this study.
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shrimp at 50% of their body weight. Daily survival of each group was observed for 8 days. The percentage of 
shrimp survival, at all sampling times, was calculated as the percentage of live shrimp from the initial shrimp 
group (n = 25). The data were analyzed using a One-Way ANOVA (SPSS ver.22, IBM).
After 8 days of cultivation, the surviving shrimp from each group were collected for evaluation of spe-
cific YHV inhibition by C. reinhardtii expressed dsRNA. Approximately 100 ng of total RNA was subjected 
to semi-quantitative RT-PCR using the primers GY2 and GY3 (Table 1), targeting the region outside of the 
dsRNA-YHV target. Actin-specific primers were used as an internal control.
Results
Generation of stable, marker-free C. reinhardtii strain expressing a specific dsRNA. The plas-
mid pSRSapI-FOI-psaAin with a dsRNA fragment specific to RdRp of YHV has been successfully generated and 
shown in Fig. 1b. This plasmid is compatible with chloroplast transformation of the Chlamydomonas reinhardtii 
strain TN72 using a glass bead method previously described11. The addition of a NotI restriction site in the plas-
mid allows for easy exchange of the FOI for other FOIs (Fig. 1a). Using the pSRSapI plasmid to transform the cell 
wall-deficient TN72 strain (∆psbH) allows for the selection of transformant colonies for phototrophic growth on 
HSM minimal medium by inserting a functional psbH gene together with the gene of interest while replacing the 
aadA antibiotic cassette present in TN72 (Fig. 2a).
After four weeks of incubation, one to two transformant colonies were obtained from transformation of TN72 
with 5–10 µg pSR-PYP plasmid DNA. A 264-bp Rubisco large-subunit fragment was amplified with the extracted 
genomic DNA to assure consistent amount and quality of the extracted chloroplast DNA (Fig. 2b-I). Detection of 
integration of dsRNA-expressed cassette into the chloroplast genome was confirmed using FOI specific primers 
presenting 374-bp amplicon, while the wild-type strain did not yield any PCR product (Fig. 2b-II). Ensuring a 
state of homoplasmy was important for genetic stability of the transformant as C. reinhardtii contains approxi-
mately 80 copies of the chloroplast genome17. We confirmed homoplasmy of the generated transformant using 
PCR on the same genomic DNA amplifying both, the FOI and the TN72 genome copy (Fig. 2b II, III). The homo-
plasmic transformant strain we obtained was named PYP and subjected to further analysis. To assess the stability 
of the generated PYP strain given that no further selection pressure was applied once the strain was confirmed to 
be homoplasmic, we periodically checked for the presence of the dsRNA-expression cassette. The FOI in the PYP 
transformant still remained detectable after the 16th passage (17 months after transformation).
Figure 2. (a) Schematic diagram of chloroplast transformation. pSR-PYP containing psbH gene and 
convergent psaA promoters covering RdRp fragment was integrated into chloroplast genome (I) through double 
homologous recombination (left and right HR) replacing spectinomycin resistance gene (aadA) resulting 
spectinomycin sensitive and photosynthesis-restoration transgenic strain (II). (b) PCR analysis for selecting 
transformant containing dsRNA-expressed cassette; (I) qualification of chloroplast genome using Rubisco-large 
subunit (not shown in the diagram a) as internal control, (II) integration of dsRNA-expressed cassette using Y1 
and Y2 primers, and (III) confirmation of homoplasmic status using W1 and W2, whereas lane M is 2-log DNA 
marker, lane TN72 and PYP represent amplicons resulting from genomic DNA extracted from TN72 and PYP, 
respectively.
5Scientific RepoRts |          (2019) 9:3164  | https://doi.org/10.1038/s41598-019-39539-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
Double-stranded RNA has no significant impact on growth of PYP strain. To investigate the 
impact on growth of dsRNA expression in the PYP strain, the growth of the strain was analyzed in comparison 
to a previously generated transformant that has the pSRSapI vector integrated in its chloroplast genome without 
a gene of interest (strain termed SR)15. This strain was chosen as a control since the TN72 strain used for trans-
formation cannot grow phototrophically. Both SR and PYP strains showed an almost identical growth pattern in 
TAP medium (Fig. 3). Early-log phase was entered on day 2 and late-log phase was reached on day 4. No signifi-
cant differences between the strains were observed.
PYP strain produces dsRNA against YHV virus. To confirm the expression of the dsRNA cassette in 
the PYP strain, we performed RT-PCR with DNase and RNase treated RNA extracts from the PYP strain. A 
dsRNA-YHV fragment of 374-bp was amplified with RT-PCR and a negative control with the same RNA extract 
confirmed no DNA contamination (data not shown). Quantitation of microalgal dsRNA was performed using 
RT-qPCR. The melting temperature (Tm) of dsRNA from C. reinhardtii PYP was the same as the purified dsRNA 
used for the standard curve (81.9 ± 0.1 °C) (Fig. 4). One liter of C. reinhardtii PYP culture in late-log phase pro-
duced 16.0 ± 0.9 ng dsRNA.
YHV-exposed shrimp survival rate increases using C. reinhardtii PYP as supplement. To demonstrate 
the antiviral efficiency of the PYP transformant expressing the anti-YHV dsRNA, a feeding trial was performed 
by feeding shrimp with PYP algae prior to exposure to the virus. Figure 5 shows the survival percentage of shrimp 
fed with C. reinhardtii PYP relative to YHV-negative and positive controls. After challenging the shrimp by 
Figure 3. Growth rate according to absorbance at wavelength 750 nm of dsRNA-expressing C. reinhardtii strain 
(PYP,--) comparing to the control strain (SR, -). Bar represents standard deviation.
Figure 4. Confirmation of dsRNA by RT-qPCR by *represents melting temperature (Tm) of dsRNA-YHV 
expressed from E. coli HT115 and dsRNA-YHV extracted from PYP strain while **represents negative reaction 
using ddH2O as a template.
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exposure to homogenized YHV-infected shrimp, the animals in the YHV-positive group died with 50% mortal-
ity at 6 days post-infection (d.p.i.) and reached 84.1 ± 16.7% mortality at 8 d.p.i. Survival in the YHV-negative 
group (no exposure to infected shrimp), on the other hand, remained significant at 70% on the last day of our 
experiment. Challenged shrimp fed with C. reinhardtii SR algal cells (no dsRNA-YHV expression) had a similar 
mortality rate to the YHV-positive group. Shrimp fed with the same amount of PYP algal cells, could however 
maintain a survival rate of up to 50% after 8 days. This was significantly different from the YHV-positive and the 
SR treatments at p < 0.01 confidence level (F value = 19.703, degrees of freedom = 3).
RT-PCR of the YHV-positive group showed that 88.9 ± 11.1% of the 9 remaining shrimp were infected with 
YHV and of 100.0 ± 0.0% the remaining 9 shrimp in the SR-treated group were infected with YHV. In contrast, in 
the group treated with PYP, YHV infection levels were significantly lower (p < 0.05) with 55.6 ± 11.1% infection 
of the remaining 27 shrimps from all tank in this group (Fig. 6).
Discussion
In this proof of concept study, we have successfully constructed an anti-YHV double-stranded RNA-expressing, 
marker-free C. reinhardtii chloroplast transformant. The goal of this study was to demonstrate the poten-
tial of using stable transgenic microalgae expressing dsRNA as a supplement for shrimp aquaculture. Due to 
the design of convenient FOI insertion and marker-free transformation system, this work can be used as an 
environmental-friendly model for producing dsRNA against other viruses.
Typically, previous studies used a hairpin DNA-structure approach7,18 for dsRNA expression, while we 
have decided to use convergent promoters for dsRNA expression in C. reinhardtii. There are several reasons 
for this choice: first, the recombination protein RECA found in plant chloroplasts (and also C. reinhardtii) 
might play a role in looping out the inverted repeats in the hairpin structure, thus leading to instability of the 
dsRNA-expression cassette19,20. Second, the use of convergent promoters allows to easily exchange the FOI to 
generate chloroplast transformation plasmids for the expression of other dsRNAs of interest. Regular checks for 
the dsRNA-expression cassette in the PYP transformant showed that very stable transformants were generated 
that do not need the application of further selection pressure. This, combined with the fact that no antibiotics are 
needed for stability, is an important attribute for large-scale applications of the transformant strains as aquacul-
ture supplement.
The overall yield of dsRNA obtained in the PYP strain, was relatively low in comparison to what was obtained 
when expressing the dsRNA in E.coli1. However, the amount produced in the PYP microalgal strain, was still 
sufficient to offer viral protection to the shrimp in a daily whole-cell feeding dose of 0.17 pg per 25 PL shrimp. At 
the same time, the dsRNA expression level did not have a negative impact on growth of the C. reinhardtii strain 
(Fig. 3). We hypothesize that whole cell dsRNA delivery might contribute to protection of dsRNA from environ-
mental degradation while potentially offering additional nutritional benefits conferred by algal consumption. 
Several studies have shown that only a few nanograms of a specific dsRNA can trigger target mRNA degrada-
tion resulting in viral copy number reduction. Alvarez-Sanchez et al. (2018) obtained a low amount of dsRNA 
from expression in the yeast Yarrowia liolytica with a maximum amount of 0.10% of total RNA (182 ng per liter 
culture)21. Intramuscular injection with 12 µg total RNA from this yeast could increase the survival of juvenile 
shrimp from White Spot Syndrome Disease (WSSD) up to 20% significantly different from control. Another 
study formulated feed with Lactobacillus plantarum expressing dsRNA thereby decreasing shrimp mortality from 
100% in the control group to 70% in the dsRNA-treated group22.
In our feeding trial, the SR group (which was fed algal cells without dsRNA expression), showed a lower mor-
tality rate between days 5 and 6, however, mortality then rose to similar levels as observed in the YHV-positive 
group. This might imply that C. reinhardtii, itself, confers nutrients or natural products, such as polyunsaturated 
fatty acids, to the shrimp aiding with combating the viral infection23,24.
To further improve the algal system presented in this proof-of-concept, using other promoters with previously 
reported high chloroplast transcription levels such as psbA or the 16S rRNA promoter may increase dsRNA 
Figure 5. Post-larval shrimp survival percentage from feeding trial comparing between observed group (no 
YHV challenge) and normal feed (YHV challenge), SR supplement prior YHV challenge, and PYP supplement 
prior YHV oral challenge. Bar represents standard error. *and **Represent significant difference between 
experiment groups within observation day at confidential level p < 0.05 and p < 0.01, respectively.
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yield and, consequently, improve shrimp viral protection25. In order to apply this algal supplement system in 
shrimp farms in the future, several aspects will have to be taken into consideration. One important point is the 
scalability of cell wall-deficient, genetically modified C. reinhardtii strains. It has previously been shown that 
transgenic strains, made with the same chloroplast transformation method as used in this study, can be scaled 
to 100 L photobioreactors26 providing first pilot-scale evidence that this microalgal dsRNA supplement could be 
implemented in larger scale reactors. Future studies will be needed to address public concerns on using living 
genetically modified organisms in aquaculture feed. For this, an algal cell inactivation process before addition to 
the shrimp feedstock should be considered.
To conclude, the dsRNA-expressing C. reinhardtii chloroplast transformants generated in this study have 
shown great potential as an effective way to fight viral diseases in shrimp aquaculture. Using whole algal cells 
as a shrimp supplement offers an easy and cost-effective oral delivery system. This system has great potential to 
be implemented in hatchery farms that produce PL shrimp. At this life stage, the shrimp are most susceptible to 
environmental changes and pathogens. Therefore, improving the overall resistance to pathogens of PL shrimp is, 
crucial for promoting sustainable farming.
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